Back
Range Cancer Therapeutics ETF Vs. Virtus LifeSci Biotech Products ETF Industry Stock Comparison
Sell
49
CNCR
Range Cancer Therapeutics ETF
Last Price:
14.00
Seasonality Move:
2.55%
Buy
70
BBP
Virtus LifeSci Biotech Products ETF
Last Price:
63.86
Seasonality Move:
5.11%
Sell
49
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $13.79. The Score for CNCR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- CNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
70
Virtus LifeSci Biotech Products ETF (BBP)
is a Buy
Is Virtus LifeSci Biotech Products ETF a Buy, Sell or Hold?
- The current Virtus LifeSci Biotech Products ETF [BBP] share price is $64.49. The Score for BBP is 70, which is 40% above its historic median score of 50, and infers lower risk than normal.
- BBP is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $13.79
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing selling pressure, which indicates risk of future bearish movement.
BBP Stock Price Chart
What is Virtus LifeSci Biotech Products ETF's stock price today?
-
The Virtus LifeSci Biotech Products ETF share price today is $64.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBP is experiencing slight buying pressure.
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.42 | Sell |
| Relative Strength Index (14 RSI): | 40.74 | Sell |
| Chaikin Money Flow: | -17976 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.81 - 15.43) | Sell |
| Bollinger Bands (100): | (14.1 - 15.46) | Sell |
BBP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.22 | Sell |
| Relative Strength Index (14 RSI): | 53.04 | Buy |
| Chaikin Money Flow: | 18 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.18 - 66.26) | Buy |
| Bollinger Bands (100): | (61.18 - 64.72) | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.55 | Buy |
| 20-day SMA: | 14.53 | Sell |
| 50-day SMA: | 14.82 | Sell |
| 200-day SMA: | 15.04 | Sell |
| 8-day EMA: | 13.77 | Buy |
| 20-day EMA: | 14.27 | Sell |
| 50-day EMA: | 14.62 | Sell |
| 200-day EMA: | 14.55 | Sell |
BBP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.55 | Buy |
| 20-day SMA: | 64.42 | Buy |
| 50-day SMA: | 63.52 | Buy |
| 200-day SMA: | 59.82 | Buy |
| 8-day EMA: | 63.37 | Buy |
| 20-day EMA: | 63.78 | Buy |
| 50-day EMA: | 63.5 | Buy |
| 200-day EMA: | 60.27 | Buy |
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Virtus LifeSci Biotech Products ETF Earnings Growth & BBP Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Virtus LifeSci Biotech Products ETF Technical Analysis
| Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||